Changes in neuroendocrine and metabolic hormones induced by atypical antipsychotics in normal-weight patients with schizophrenia. - Wikidata - wikimedia - TriplyDB

Changes in neuroendocrine and metabolic hormones induced by atypical antipsychotics in normal-weight patients with schizophrenia.

Changes in neuroendocrine and metabolic hormones induced by atypical antipsychotics in normal-weight patients with schizophrenia.

http://www.wikidata.org/entity/Q47283583

about

Molecular substrates of schizophrenia: homeostatic signaling to connectivity A randomised controlled study of risperidone and olanzapine for schizophrenic patients with neuroleptic-induced acute dystonia or parkinsonism.Almost all antipsychotics result in weight gain: a meta-analysis.Antipsychotic-induced changes in blood levels of leptin in schizophrenia: a meta-analysis.The role of leptin in antipsychotic-induced weight gain: genetic and non-genetic factors Abnormal cortisol levels during the day and cortisol awakening response in first-episode psychosis: the role of stress and of antipsychotic treatment Antipsychotic drugs opposite to metabolic risk: neurotransmitters, neurohormonal and pharmacogenetic mechanisms underlying with weight gain and metabolic syndrome Leptin and ghrelin levels in patients with schizophrenia during different antipsychotics treatment: a review.Antipsychotic induced weight gain in schizophrenia:mechanisms and management.Effect of body mass index on peak growth hormone response to provocative testing in children with short stature.A systematic review of hypothalamic-pituitary-adrenal axis function in schizophrenia: implications for mortality.Atypical antipsychotic-induced weight gain: insights into mechanisms of action.Haloperidol affects bones while clozapine alters metabolic parameters - sex specific effects in rats perinatally treated with phencyclidine Qualitative descriptive study exploring schizophrenia and the everyday effect of medication-induced weight gain.Risperidone-induced polydipsia and polyphagia associated with galactorrhea, abdominal pain, and rapid weight gain in an adolescent Hispanic female.Bone remodeling, bone mass and weight gain in patients with stabilized schizophrenia in real-life conditions treated with long-acting injectable risperidone.Association between antipsychotic treatment and leptin levels across multiple psychiatric populations: An updated meta-analysis.Efﬁcacy and metabolic influence of paliperidone ER, aripiprazole and ziprasidone to patients with first-episode schizophrenia through 52 weeks follow-up in China.

P2860

Q30383611-77886E1C-F304-4316-AD38-190A52CFDC1B Q34183522-E1AE678F-72B2-44E0-A125-90FAB87BFF31 Q34661499-3089E514-35BB-40B0-8377-296A11C371FB Q35566086-C60A7834-1F13-4A63-BB9E-495E071033E8 Q35864617-72018AC5-E1A5-49B7-A109-7FE8DC2E773B Q36442033-E0B00E8B-283D-4368-8767-046D5887F1AD Q37043479-8B86853B-1190-4A6B-B2D5-6B0FE9615B42 Q37047473-0F07E6B6-0FB5-4FB2-B6F3-EEEFAF6900AC Q37160453-F1356259-61FC-423A-BB9F-2E14FB396519 Q37482808-3ED7343D-E7B3-4710-B5AF-D299031EEB44 Q37798087-E103060C-5B2B-42CD-97C4-10367BE06342 Q37963571-5ACFF6B8-9E50-4B0E-87BA-52F36EFEEC4B Q42375259-AF7F8513-1460-47BA-BBCD-B755AFB6F49E Q43757239-4BE3D171-3919-40ED-BBFD-56B991360459 Q46913098-CC97FCB2-18A9-46E3-A2F4-9A381DCF3FCA Q47350555-5DC2CB74-DC2A-433C-8BBD-99BDBE7E01F7 Q47605999-6E1FA213-E95E-4BDF-B96E-C6DDF05A1BEA Q50737699-A276F08C-BE11-4417-A563-93B86832B81E

P2860

Changes in neuroendocrine and metabolic hormones induced by atypical antipsychotics in normal-weight patients with schizophrenia.

http://www.wikidata.org/entity/Q47283583

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年学术文章

@wuu

2007年学术文章

@zh

2007年学术文章

@zh-cn

2007年学术文章

@zh-hans

2007年学术文章

@zh-my

2007年学术文章

@zh-sg

2007年學術文章

@yue

2007年學術文章

@zh-hant

name

Changes in neuroendocrine and ...... t patients with schizophrenia.

@en

Changes in neuroendocrine and ...... t patients with schizophrenia.

@nl

type

label

Changes in neuroendocrine and ...... t patients with schizophrenia.

@en

Changes in neuroendocrine and ...... t patients with schizophrenia.

@nl

prefLabel

Changes in neuroendocrine and ...... t patients with schizophrenia.

@en

Changes in neuroendocrine and ...... t patients with schizophrenia.

@nl

P1433

Q47283583-D93B17BB-63A4-4532-80E5-054FB87B16FE

P1476

Q47283583-883CE27D-8882-4A5D-88E7-EB573169C4E3

P2093

Q47283583-02288913-18D1-4E1E-8FA3-50D8BBAD5C1A

Q47283583-03D265C4-7CCE-4B4D-9FEC-EE82DE55971B

Q47283583-4A521A58-CEA9-4254-815F-C71F20D3252D

Q47283583-65160DC1-25F7-4E72-9A0F-70B2768E6B55

Q47283583-6BA199D9-59E7-4555-922C-D030E19CE591

Q47283583-6D424752-ED2A-4383-BC3E-61D948BF32B3

Q47283583-8847DF71-E883-4E88-BF66-744DE44F9835

Q47283583-B74D2D4C-EE01-4CD9-9625-3C6203F2D3D9

Q47283583-C87170A5-15E4-4D52-A93A-FAB16E3BB856

Q47283583-F5FACE5B-1ECB-43D6-84C1-9291B10F97FD

P2860

Q47283583-0728ACF5-DD12-4E77-BDA3-7EC82426B08D

Q47283583-0935EAC6-2ABD-48C5-9257-9EDF5C1FFFBA

Q47283583-19F1078C-718B-4D5D-9BA4-0D2F4FA3D2B1

Q47283583-1D5DB414-BEDB-4EC6-AE3F-E0A93F4AF1CB

Q47283583-2EC27E93-2C08-4263-B7D3-049717B4109A

Q47283583-62748BF1-14E0-4383-BF96-0C2375CAE9CD

Q47283583-817E6E28-D4E0-4F49-93A8-DCB9F1E6C81E

Q47283583-A64C2B57-705C-45F5-AADC-59DD4E748B01

Q47283583-B53629C0-6D57-440F-B87E-CE0AF937B8DF

Q47283583-C0BD0FA5-9145-469A-811C-D8DE499C184A

P304

Q47283583-09E4CA29-3781-4C84-B2F4-2A5CC4543234

P31

Q47283583-55FDB9EA-0120-4E9E-92D3-B95694C5B0C1

P356

Q47283583-40CC1A18-05B7-41E2-ABFE-C7C8059D4E64

P433

Q47283583-0567C9E7-ED20-4E08-9CD3-DD230D614593

P478

Q47283583-DEEDE8D5-CA36-42CC-A6C2-58DE34C1CE59

P577

Q47283583-852C2C45-B2D7-4505-B520-5C2A550A6607

P698

Q47283583-E633321F-60EE-4391-84AC-BA1DCCD7E0CB

P921

Q47283583-84C43F2A-A5AF-4020-9E0B-39AE59E166F9

P356

P1433

Neuroendocrinology

P1476

Changes in neuroendocrine and ...... t patients with schizophrenia.

@en

P2093

Aleksandar Damjanovic

http://www.w3.org/2001/XMLSchema#string

Carlos Dieguez

http://www.w3.org/2001/XMLSchema#string

Dragana Miljic

http://www.w3.org/2001/XMLSchema#string

Felipe F Casanueva

http://www.w3.org/2001/XMLSchema#string

Marina Djurovic

http://www.w3.org/2001/XMLSchema#string

Mirjana Doknic

http://www.w3.org/2001/XMLSchema#string

Miroslava Jasovic-Gasic

http://www.w3.org/2001/XMLSchema#string

Nadja Maric

http://www.w3.org/2001/XMLSchema#string

Natasa Miljic

http://www.w3.org/2001/XMLSchema#string

Sandra Pekic

http://www.w3.org/2001/XMLSchema#string

P2860

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

The positive and negative syndrome scale (PANSS) for schizophrenia

Serum immunoreactive-leptin concentrations in normal-weight and obese humans

Plasma ghrelin levels in lean and obese humans and the effect of glucose on ghrelin secretion.

Decreased cerebrospinal-fluid/serum leptin ratio in obesity: a possible mechanism for leptin resistance.

Human leptin levels are pulsatile and inversely related to pituitary-adrenal function.

Minireview: From anorexia to obesity--the yin and yang of body weight control.

Abnormalities in glucose regulation during antipsychotic treatment of schizophrenia.

Biological, physiological, pathophysiological, and pharmacological aspects of ghrelin.

Hyperglycaemia suppresses the secretion of ghrelin, a novel growth-hormone-releasing peptide: responses to the intravenous and oral administration of glucose.

P304

249-256

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1159/000103868

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

85

http://www.w3.org/2001/XMLSchema#string

P577

2007-06-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17570902

http://www.w3.org/2001/XMLSchema#string

P921